PAQR6 and breast carcinoma: Interestingly, when we repeated our analysis utilizing a different breast cancer database (TCGA), we confirmed that decreased expression of PAQR6 had the worst overall survival (OS) (Fig. 2C, top panel) for Luminal-A breast cancer patients, validating our previous results using a separate cohort (Fig. 2B).